DEK::NUP214白血病的XPO1依赖性
Fiorella Charles Cano1, Arnold Kloos1, Rucha Y Hebalkar2
1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Leukemia
|March 28, 2025
概括
针对核出口蛋白XPO1的向显示出对治疗DEK::NUP214急性髓性白血病 (AML) 的希望. 抑制XPO1会破坏致癌的DEK::NUP214融合蛋白.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 血液学 血液学 血液学
背景情况:
- 核出口蛋白XPO1与NUP214相互作用,有助于SET::NUP214急性髓性白血病 (AML) 的发病.
- DEK::NUP214 (DN) 定义了一个独特的反洗钱实体,其对XPO1的依赖以前没有被描述.
研究的目的:
- 评估DEK::NUP214 (DN) AML在XPO1.1上的依赖性.
- 在DN-AML模型中研究XPO1抑制的治疗潜力.
主要方法:
- 使用了人类AML细胞系 (FKH-1) 和初级细胞.
- 使用了选择性核出口抑制剂eltanexor.
- 评估了XPO1的表达,蛋白质的同定位,细胞亡,细胞循环停止和染色体结合.
- 评估了一个来自患者的DN-AML异种移植模型.
主要成果:
- 在DN阳性细胞中,XPO1删除和ELTANEXOR治疗诱导了细胞亡和细胞循环停止.
- 抑制XPO1干扰了XPO1和DN在染色质的同定位.
- 染色质结合的丧失导致了参与细胞循环和自我更新的DNA基因的下调.
- 在异种移植模型中,Eltanexor治疗显著延迟了白血病的发展.
结论:
- XPO1 稳定了 DEK::NUP214 融合蛋白在染色质上,激活了其致癌基因特征.
- 用埃尔塔尼克索准XPO1证明了DN-AML在体内治疗的成功.
- XPO1已被确立为DEK::NUP214 AML治疗的可行的分子标.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Lineage Commitment
Commitment is the process whereby stem cells:
Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...


